Fact check · Version 1 · Sources checked

“Forzinity is FDA-approved for a narrow Barth syndrome use.”

The Peptide Field explains research. Its pages are not independently medically reviewed, and they do not diagnose, prescribe, or recommend treatment.

Supported with scope

The reviewed evidence supports this exact statement only in the situation described below.

FDA granted accelerated approval for Forzinity to improve muscle strength in adults and children with Barth syndrome who weigh at least 30 kg. Accelerated approval uses an intermediate measure and requires a confirmatory study.

What this answer is based on
This answer uses an official regulator record or a specific product label.
Limits of this answer
The Forzinity label and FDA approval records as reviewed August 30, 2026. These limits show which substance, product, people, use, place, and time the answer covers. A different product or situation can have a different answer.
Topic
Whether a specific product has an approval or another official status.

Sources for this fact check

Show 3 sources
Sources checked by
Site editor · Editorial review

More about SS-31

See the FDA and sports-rule status of SS-31

Other fact checks on SS-31